Double-blind and Placebo-controlled Study on Intervention Effect of Medium and Long Chain Fatty Acid Triglyceride on Glycolipid Homeostasis in Patients With Metabolic Syndrome and Mechanisms

Double-blind and Placebo-controlled Study on Intervention Effect of Medium and Long Chain Fatty Acid Triglyceride on Glycolipid Homeostasis in Patients With Metabolic Syndrome and Mechanisms

Double-blind and placebo-controlled study on intervention effect of medium and long chain fatty acid triglyceride on glycolipid homeostasis in patients with metabolic syndrome and mechanisms

Inclusion Criteria:

• Diagnosed metabolic syndrome according to IDF diagnostic criteria;
• Rarely eating out of home;
• Aged between 40 and 70 years.

Exclusion Criteria:

• Breastfeeding or pregnancy;
• History of heart disease, coronary heart disease, stroke, cerebral infarction, viral liver disease (hepatitis A, hepatitis B, etc.), chronic kidney disease (GFR<60 ml/min) or cancer;
• Diabetic ketoacidosis or hyperketosis;
• Drug use has changed in the past six months;
• Taking insulin;
• Used MLCT edible oil in the past six months;
• Have participated in other clinical trials in the last three months.